Diagnostic imaging company RadNet (NASDAQ:RDNT) will be announcing earnings results tomorrow morning. Here’s what you need to know.

RadNet beat analysts’ revenue expectations by 4.2% last quarter, reporting revenues of $477.1 million, up 13.5% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ same-store sales and EPS estimates.

Is RadNet a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting RadNet’s revenue to grow 2.6% year on year to $443 million, slowing from the 10.5% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.13 per share.RadNet Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. RadNet has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 3.5% on average.

Looking at RadNet’s peers in the testing & diagnostics services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Guardant Health delivered year-on-year revenue growth of 20.8%, beating analysts’ expectations by 6.9%, and NeoGenomics reported revenues up 7.5%, falling short of estimates by 1.7%. Guardant Health traded up 3.7% following the results while NeoGenomics was down 35.9%.

Read our full analysis of Guardant Health’s results here and NeoGenomics’s results here.

Investors in the testing & diagnostics services segment have had steady hands going into earnings, with share prices up 1.5% on average over the last month. RadNet is up 4.4% during the same time and is heading into earnings with an average analyst price target of $71.67 (compared to the current share price of $55.73).

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

View Comments